Indefinite Delivery Contract 75N98020D00050

Award Date 4/20/20
Last Date to Order 4/19/26
Funding Federal Agency
Office of the Director
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The National Institutes of Health (NIH) awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Leydig, Voit & Mayer, LTD., an internationally recognized law firm specializing in intellectual property and patent-related legal services. The $115 million multiple-award IDIQ contract covers patent legal services across four technology categories: biotechnology, chemistry, mechanical engineering, and software. Through this centralized contract vehicle, various NIH institutes and...
The National Institutes of Health (NIH) awarded Leydig, Voit & Mayer, LTD., an intellectual property law firm, an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to provide patent-related legal services across four technology categories: biotechnology, chemistry, mechanical engineering, and software. The $17 million IDIQ contract has a ten-year ordering period and allows various NIH institutes, as well as the Centers for Disease Control and Prevention, to issue task orders for...
The National Institutes of Health (NIH) awarded an Indefinite Delivery Contract with a ceiling value of $17 million to Leydig, Voit & Mayer, LTD., an internationally recognized intellectual property law firm, to provide patent-related legal services. The multiple-award contract covers four technology categories: biotechnology, chemistry, mechanical engineering, and software. Under this contract, Leydig, Voit & Mayer will perform a range of patent prosecution activities, including...
The Department of Health and Human Services' National Institutes of Health (NIH) has awarded an indefinite-delivery/indefinite-quantity (IDIQ) contract with a total potential value of $386 million to Sughrue Mion, PLLC, a law firm specializing in intellectual property law. This multiple-award IDIQ contract provides patent prosecution and counseling services to support NIH's biomedical research objectives, including preparing and filing domestic and international patent applications. The IDIQ...
The Department of Health and Human Services National Institutes of Health (NIH) awarded an indefinite-delivery/indefinite-quantity (IDIQ) master contract for patent legal services to McDonnell Boehnen Hulbert & Berghoff LLP, a law firm providing intellectual property expertise. The $115 million contract has a 5-year ordering period and covers patent prosecution, filing, strategy development, and related services across four technology categories: biotechnology, chemistry, mechanical...
The National Institutes of Health (NIH) has awarded multiple indefinite-delivery/indefinite-quantity (IDIQ) contracts under the NIH Patent Legal Services master agreement to McDonnell Boehnen Hulbert & Berghoff LLP (MBHB), a law firm providing intellectual property legal services. The IDIQ contracts, valued at over $500 million combined, cover patent-related legal work for NIH and potentially the Centers for Disease Control and Prevention across four technology categories: biotechnology,...
The National Institutes of Health (NIH) awarded an indefinite-delivery/indefinite-quantity (IDIQ) master contract for patent legal services across four technology categories: biotechnology, chemistry, mechanical engineering, and software. The $520 million multiple-award IDIQ, managed by the NIH Office of Logistics and Acquisition Operations, provides task order-based services such as patent prosecution, intellectual property protection, and related legal activities to support NIH's technology...
The National Institutes of Health (NIH) has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Polsinelli PC, an Am Law 100 law firm, to provide patent legal services across four technology areas: biotechnology, chemistry, mechanical engineering, and software. The multiple-award, $386 million IDIQ has a base period of one year with up to nine option years. Under the contract, Polsinelli will perform patent prosecution, prior art searches, and patent application filing services...
The Department of Health and Human Services National Institutes of Health (NIH) has awarded a multiple-award indefinite-delivery/indefinite-quantity (IDIQ) contract for patent legal services to Cantor Colburn LLP, a leading intellectual property law firm. The $115 million NIH Patent Legal Services IDIQ enables NIH institutes, centers, and the Centers for Disease Control and Prevention to obtain patent prosecution, counseling, and litigation support services through firm-fixed price and...
The National Institutes of Health (NIH) awarded a multiple-award indefinite delivery/indefinite quantity (IDIQ) contract for patent legal services to Polsinelli PC, an Am Law 100 law firm with expertise in intellectual property and patent law. The $17 million contract, which has a period of performance through April 2025, provides for firm fixed price and time and materials task orders to support patent prosecution, prior art searches, and patent application filing services for NIH's various...

The Department of Health and Human Services' National Institutes of Health (NIH) awarded a multiple award indefinite-delivery/indefinite-quantity (IDIQ) contract to Leydig, Voit & Mayer, LTD., a for-profit law firm specializing in intellectual property and patent legal services. The $386 million IDIQ covers patent-related legal services across four technology domains: biotechnology, chemistry, mechanical engineering, and software.

Leydig, Voit & Mayer holds multiple delivery order contracts under this IDIQ to provide services such as patent application preparation and filing, patent prosecution, prior art searches, and general patent-related legal counsel in support of NIH's biomedical research and technology transfer initiatives. The delivery orders range from $5,300 to $4.4 million and are awarded by various NIH institutes and centers, as well as the Centers for Disease Control and Prevention, with no set-aside designations. The work is primarily performed in Chicago, Illinois and supports the NIH's extensive patent portfolio, which includes nearly 2,500 active cases and 200-300 new applications filed annually.

Generated 4/4/25, 9:43 AM